المؤلفون: Joeri Meijsen, Kejia Hu, Morten D. Krebs, Georgios Athanasiadis, Sarah Washbrook, Richard Zetterberg, Raquel Nogueira Avelar e Silva, John R. Shorter, Jesper R. Gådin, Jacob Bergstedt, David M. Howard, Weimin Ye, Yi Lu, Unnur A. Valdimarsdóttir, Andrés Ingason, Dorte Helenius, Oleguer Plana-Ripoll, John J. McGrath, Nadia Micali, Ole A. Andreassen, Thomas M. Werge, Fang Fang, Alfonso Buil

المصدر: Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)

مصطلحات موضوعية: Science

الوصف: Abstract Mental disorders are leading causes of disability and premature death worldwide, partly due to high comorbidity with cardiometabolic disorders. Reasons for this comorbidity are still poorly understood. We leverage nation-wide health records and near-complete genealogies of Denmark and Sweden (n = 17 million) to reveal the genetic and environmental contributions underlying the observed comorbidity between six mental disorders and 15 cardiometabolic disorders. Genetic factors contributed about 50% to the comorbidity of schizophrenia, affective disorders, and autism spectrum disorder with cardiometabolic disorders, whereas the comorbidity of attention-deficit/hyperactivity disorder and anorexia with cardiometabolic disorders was mainly or fully driven by environmental factors. In this work we provide causal insight to guide clinical and scientific initiatives directed at achieving mechanistic understanding as well as preventing and alleviating the consequences of these disorders.

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2041-1723Test

الوصول الحر: https://doaj.org/article/b590855b0172469c974a0c55e5a42e1dTest

المؤلفون: Karina Banasik, Christian Erikstrup, Ole Birger Pedersen, Kaspar Nielsen, Henrik Hjalgrim, Thomas Werge, Sisse R Ostrowski, Michael Schwinn, Maria Didriksen, Susanne Sækmose, Lea AN Christoffersen, Dorte Helenius, Janna Nissen, Kathrine A Kaspersen, Khoa M Dinh, Mie T Bruun, Thomas F Hansen

المصدر: BMJ Open, Vol 13, Iss 4 (2023)

مصطلحات موضوعية: Medicine

الوصف: Objectives To examine the level of loneliness experienced during the COVID-19 pandemic in Denmark and to identify associated behavioural patterns and demographic factors.Design Cross-sectional cohort study.Setting Includes Danish active and former blood donors.Participants A questionnaire was sent to 124 307 active and former blood donors, of these a total of 50 968 participants completed the study questionnaire (response rate=41%).Primary and secondary outcome measures Subjective experience of loneliness was measured using the 3-item University of California, Los Angeles Loneliness Scale (UCLA-3). Besides the UCLA-3, the respondents answered items on sociodemographic and economic characteristics, items on precautionary measures taken to avoid COVID-19 infection as well as on COVID-19 anxiety.Results The participants indicated their experienced level of loneliness both before and during the pandemic. Comparing the two reports yielded a mean increase in loneliness scores of 14.1% (p

وصف الملف: electronic resource

العلاقة: https://bmjopen.bmj.com/content/13/4/e064033.fullTest; https://doaj.org/toc/2044-6055Test

الوصول الحر: https://doaj.org/article/a9214641605b4634927a8bc833be71d8Test

المؤلفون: Xueping Liu, Dorte Helenius, Line Skotte, Robin N. Beaumont, Matthias Wielscher, Frank Geller, Julius Juodakis, Anubha Mahajan, Jonathan P. Bradfield, Frederick T. J. Lin, Suzanne Vogelezang, Mariona Bustamante, Tarunveer S. Ahluwalia, Niina Pitkänen, Carol A. Wang, Jonas Bacelis, Maria C. Borges, Ge Zhang, Bruce A. Bedell, Robert M. Rossi, Kristin Skogstrand, Shouneng Peng, Wesley K. Thompson, Vivek Appadurai, Debbie A. Lawlor, Ilkka Kalliala, Christine Power, Mark I. McCarthy, Heather A. Boyd, Mary L. Marazita, Hakon Hakonarson, M. Geoffrey Hayes, Denise M. Scholtens, Fernando Rivadeneira, Vincent W. V. Jaddoe, Rebecca K. Vinding, Hans Bisgaard, Bridget A. Knight, Katja Pahkala, Olli Raitakari, Øyvind Helgeland, Stefan Johansson, Pål R. Njølstad, João Fadista, Andrew J. Schork, Ron Nudel, Daniel E. Miller, Xiaoting Chen, Matthew T. Weirauch, Preben Bo Mortensen, Anders D. Børglum, Merete Nordentoft, Ole Mors, Ke Hao, Kelli K. Ryckman, David M. Hougaard, Leah C. Kottyan, Craig E. Pennell, Leo-Pekka Lyytikainen, Klaus Bønnelykke, Martine Vrijheid, Janine F. Felix, William L. Lowe, Struan F. A. Grant, Elina Hyppönen, Bo Jacobsson, Marjo-Riitta Jarvelin, Louis J. Muglia, Jeffrey C. Murray, Rachel M. Freathy, Thomas M. Werge, Mads Melbye, Alfonso Buil, Bjarke Feenstra

المصدر: Nature Communications, Vol 10, Iss 1, Pp 1-13 (2019)

مصطلحات موضوعية: Science

الوصف: Gestational duration depends on both maternal and fetal genetic influences. Here, the authors perform a fetal genome-wide association meta-analysis and find that a locus on 2q13 is associated with pregnancy duration and further show that the lead SNP rs7594852 changes the binding properties of transcriptional repressor HIC1.

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2041-1723Test

الوصول الحر: https://doaj.org/article/0663e700e52e44dd96778ff7a9670192Test

المؤلفون: Rikke Hilker, Dorte Helenius, Birgitte Fagerlund, Axel Skytthe, Kaare Christensen, Thomas M. Werge, Merete Nordentoft, Birte Glenthøj

المصدر: EBioMedicine, Vol 18, Iss C, Pp 320-326 (2017)

مصطلحات موضوعية: Twin study, Age at onset, Schizophrenia, Nationwide register-based data, Medicine, Medicine (General), R5-920

الوصف: Background: Early age at illness onset has been viewed as an important liability marker for schizophrenia, which may be associated with an increased genetic vulnerability. A twin approach can be valuable, because it allows for the investigation of specific illness markers in individuals with a shared genetic background. Methods: We linked nationwide registers to identify a cohort of twin pairs born in Denmark from 1951 to 2000 (N = 31,524 pairs), where one or both twins had a diagnosis in the schizophrenia spectrum. We defined two groups consisting of; N = 788 twin pairs (affected with schizophrenia spectrum) and a subsample of N = 448 (affected with schizophrenia). Survival analysis was applied to investigate the effect of age at illness onset. Findings: We found that early age at illness onset compared to later onset in the first diagnosed twin can be considered a major risk factor for developing schizophrenia in the second twin. Additionally, we found that the stronger genetic component in MZ twins compared to DZ twins is manifested in the proximity of assigned diagnosis within pairs. Discussion: Early onset schizophrenia could be linked to a more severe genetic predisposition, indicating that age might be perceived as a clinical marker for genetic vulnerability for the illness.

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2352396417301445Test; https://doaj.org/toc/2352-3964Test

الوصول الحر: https://doaj.org/article/13db1d8612324fb488c1e7e97378dd15Test

المؤلفون: Shen, Qing, Mikkelsen, Dorte Helenius, Luitva, Laura Birgit, Song, Huan, Kasela, Silva, Aspelund, Thor, Bergstedt, Jacob, Lu, Yi, Sullivan, Patrick F., Ye, Weimin, Fall, Katja, 1971, Tornvall, Per, Pawitan, Yudi, Andreassen, Ole A., Buil, Alfonso, Milani, Lili, Fang, Fang, Valdimarsdóttir, Unnur

المصدر: eClinicalMedicine. 61

مصطلحات موضوعية: Cardiovascular disease, Disease trajectory, Family design, Psychiatric disorders, Sibling

الوصف: BACKGROUND: Several psychiatric disorders have been associated with increased risk of cardiovascular disease (CVD), however, the role of familial factors and the main disease trajectories remain unknown.METHODS: In this longitudinal cohort study, we identified a cohort of 900,240 patients newly diagnosed with psychiatric disorders during January 1, 1987 and December 31, 2016, their 1,002,888 unaffected full siblings, and 1:10 age- and sex-matched reference population from nationwide medical records in Sweden, who had no prior diagnosis of CVD at enrolment. We used flexible parametric models to determine the time-varying association between first-onset psychiatric disorders and incident CVD and CVD death, comparing rates of CVD among patients with psychiatric disorders to the rates of unaffected siblings and matched reference population. We also used disease trajectory analysis to identify main disease trajectories linking psychiatric disorders to CVD. Identified associations and disease trajectories of the Swedish cohort were validated in a similar cohort from nationwide medical records in Denmark (N = 875,634 patients, same criteria during January 1, 1969 and December 31, 2016) and in Estonian cohorts from the Estonian Biobank (N = 30,656 patients, same criteria during January 1, 2006 and December 31, 2020), respectively.FINDINGS: During up to 30 years of follow-up of the Swedish cohort, the crude incidence rate of CVD was 9.7, 7.4 and 7.0 per 1000 person-years among patients with psychiatric disorders, their unaffected siblings, and the matched reference population. Compared with their siblings, patients with psychiatric disorders experienced higher rates of CVD during the first year after diagnosis (hazard ratio [HR], 1.88; 95% confidence interval [CI], 1.79-1.98) and thereafter (1.37; 95% CI, 1.34-1.39). Similar rate increases were noted when comparing with the matched reference population. These results were replicated in the Danish cohort. We identified several disease trajectories linking psychiatric disorders to CVD in the Swedish cohort, with or without mediating medical conditions, including a direct link between psychiatric disorders and hypertensive disorder, ischemic heart disease, venous thromboembolism, angina pectoris, and stroke. These trajectories were validated in the Estonian Biobank cohort.INTERPRETATION: Independent of familial factors, patients with psychiatric disorders are at an elevated risk of subsequent CVD, particularly during first year after diagnosis. Increased surveillance and treatment of CVDs and CVD risk factors should be considered as an integral part of clinical management, in order to reduce risk of CVD among patients with psychiatric disorders.

وصف الملف: print

الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-107069Test
https://doi.org/10.1016/j.eclinm.2023.102063Test

المؤلفون: Shen, Qing, Joyce, Emily E., Ebrahimi, Omid V., Didriksen, Maria, Lovik, Anikó, Sævarsdóttir, Karen Sól, Magnúsdóttir, Ingibjörg, Mikkelsen, Dorte Helenius, Unnarsdóttir, Anna Bára, Hauksdóttir, Arna, Hoffart, Asle, Kähler, Anna K., Þórðardóttir, Edda Björk, Eythórsson, Elías, Frans, Emma M., Tómasson, Gunnar, Ask, Helga, Harðardóttir, Hrönn, Jakobsdóttir, Jóhanna, Lehto, Kelli, Lu, Li, Andreassen, Ole A., Sullivan, Patrick F., Pálsson, Runólfur, Erikstrup, Christian, Ostrowski, Sisse Rye, Werge, Thomas, Aspelund, Thor, Pedersen, Ole B.V., Johnson, Sverre Urnes, Fang, Fang, Valdimarsdóttir, Unnur Anna

المساهمون: Faculty of Medicine, Other departments, Interdisciplinary Graduate Studies, Landspitali - The National University Hospital of Iceland

مصطلحات موضوعية: Sálfræði, Gigtarlæknisfræði, Lungnalæknisfræði, Nýrnalæknisfræði, Cohort, COVID-19, Long covid, Physical symptom, Internal Medicine, Oncology, Health Policy

الوصف: Publisher Copyright: © 2023 The Author(s) ; Background: Although the persistence of physical symptoms after SARS-CoV-2 infection is a major public health concern, evidence from large observational studies beyond one year post diagnosis remain scarce. We aimed to assess the prevalence of physical symptoms in relation to acute illness severity up to more than 2-years after diagnosis of COVID-19. Methods: This multinational study included 64,880 adult participants from Iceland, Sweden, Denmark, and Norway with self-reported data on COVID-19 and physical symptoms from April 2020 to August 2022. We compared the prevalence of 15 physical symptoms, measured by the Patient Health Questionnaire (PHQ-15), among individuals with or without a confirmed COVID-19 diagnosis, by acute illness severity, and by time since diagnosis. We additionally assessed the change in symptoms in a subset of Swedish adults with repeated measures, before and after COVID-19 diagnosis. Findings: During up to 27 months of follow-up, 34.5% participants (22,382/64,880) were diagnosed with COVID-19. Individuals who were diagnosed with COVID-19, compared to those not diagnosed, had an overall 37% higher prevalence of severe physical symptom burden (PHQ-15 score ≥15, adjusted prevalence ratio [PR] 1.37 [95% confidence interval [CI] 1.23–1.52]). The prevalence was associated with acute COVID-19 severity: individuals bedridden for seven days or longer presented with the highest prevalence (PR 2.25 [1.85–2.74]), while individuals never bedridden presented with similar prevalence as individuals not diagnosed with COVID-19 (PR 0.92 [0.68–1.24]). The prevalence was statistically significantly elevated among individuals diagnosed with COVID-19 for eight of the fifteen measured symptoms: shortness of breath, chest pain, dizziness, heart racing, headaches, low energy/fatigue, trouble sleeping, and back pain. The analysis of repeated measurements rendered similar results as the main analysis. Interpretation: These data suggest an elevated prevalence of some, but ...

العلاقة: The Lancet Regional Health - Europe; 35(); http://www.scopus.com/inward/record.url?scp=85177793701&partnerID=8YFLogxKTest; Shen , Q , Joyce , E E , Ebrahimi , O V , Didriksen , M , Lovik , A , Sævarsdóttir , K S , Magnúsdóttir , I , Mikkelsen , D H , Unnarsdóttir , A B , Hauksdóttir , A , Hoffart , A , Kähler , A K , Þórðardóttir , E B , Eythórsson , E , Frans , E M , Tómasson , G , Ask , H , Harðardóttir , H , Jakobsdóttir , J , Lehto , K , Lu , L , Andreassen , O A , Sullivan , P F , Pálsson , R , Erikstrup , C , Ostrowski , S R , Werge , T , Aspelund , T , Pedersen , O B V , Johnson , S U , Fang , F & Valdimarsdóttir , U A 2023 , ' COVID-19 illness severity and 2-year prevalence of physical symptoms : an observational study in Iceland, Sweden, Norway and Denmark ' , The Lancet Regional Health - Europe , vol. 35 , 100756 , pp. 100756 . https://doi.org/10.1016/j.lanepe.2023.100756Test; 213452595; da60705a-5cf7-46ff-9828-828700a08e68; 85177793701; unpaywall: 10.1016/j.lanepe.2023.100756; https://hdl.handle.net/20.500.11815/4669Test

الإتاحة: https://doi.org/20.500.11815/4669Test
https://doi.org/10.1016/j.lanepe.2023.100756Test
https://hdl.handle.net/20.500.11815/4669Test

المؤلفون: Unnarsdóttir, Anna Bára, Lovik, Anikó, Fawns-Ritchie, Chloe, Ask, Helga, Koiv, Kadri, Hagen, Kristen, Didriksen, Maria, Christoffersen, Lea Arregui Nordahl, Gardarsson, Alexander Berg, McIntosh, Andrew, Kähler, Anna K., Campbell, Archie, Hauksdóttir, Arna, Erikstrup, Christian, Mikkelsen, Dorte Helenius, Altschul, Drew, Thordardottir, Edda Bjork, Frans, Emma Maria, Kvale, Gerd, Tómasson, Gunnar, Kariis, Hanna Maria, Jónsdóttir, Harpa Lind, Rúnarsdóttir, Harpa, Magnúsdóttir, Ingibjörg, Eid, Jarle, Jakobsdóttir, Jóhanna, Nielsen, Kaspar René, Kaspersen, Kathrine Agergard, Milani, Lili, Schou Trogstad, Lill Iren, Yi, Lu, Bruun, Mie Topholm, Sullivan, Patrick F., Magnus, Per Minor, Shen, Qing, Nesvag, Ragnar, Brandlistuen, Ragnhild E., Mägi, Reedik, Ostrowski, Sisse Rye, Løkhammer, Solveig, Solem, Stian, Reichborn-Kjennerud, Ted, Hansen, Thomas Folkmann, Werge, Thomas, Aspelund, Thor, Porteous, David J., Fang, Fang, Lehto, Kelli, Andreassen, Ole A., Pedersen, Ole Birger Vesterager, Le Hellard, Stephanie, Valdimarsdóttir, Unnur A.

المصدر: Unnarsdóttir , A B , Lovik , A , Fawns-Ritchie , C , Ask , H , Koiv , K , Hagen , K , Didriksen , M , Christoffersen , L A N , Gardarsson , A B , McIntosh , A , Kähler , A K , Campbell , A , Hauksdóttir , A , Erikstrup , C , Mikkelsen , D H , Altschul , D , Thordardottir , E B , Frans , E M , Kvale , G , Tómasson , G , Kariis , H M , Jónsdóttir , H L , Rúnarsdóttir ....

مصطلحات موضوعية: /dk/atira/pure/subjectarea/asjc/2700/2713, name=Epidemiology

وصف الملف: application/pdf

العلاقة: https://discovery.dundee.ac.uk/en/publications/68753953-4ade-4a1a-96a2-bf407e232e07Test

الإتاحة: https://doi.org/10.1093/ije/dyab234Test
https://discovery.dundee.ac.uk/en/publications/68753953-4ade-4a1a-96a2-bf407e232e07Test
https://discovery.dundee.ac.uk/ws/files/100052936/dyab234.pdfTest
http://www.scopus.com/inward/record.url?scp=85132816164&partnerID=8YFLogxKTest

المؤلفون: Unnarsdóttir, Anna Bára, Lovik, Anikó, Fawns-Ritchie, Chloe, Ask, Helga, Kõiv, Kadri, Hagen, Kristen, Didriksen, Maria, Christoffersen, Lea Arregui Nordahl, Garðarsson, Alexander Berg, McIntosh, Andrew, Kähler, Anna K., Campbell, Archie, Hauksdóttir, Arna, Erikstrup, Christian, Mikkelsen, Dorte Helenius, Altschul, Drew, Thordardottir, Edda Bjork, Frans, Emma Maria, Kvale, Gerd, Tómasson, Gunnar, Kariis, Hanna Maria, Jónsdóttir, Harpa Lind, Rúnarsdóttir, Harpa, Magnúsdóttir, Ingibjörg, Eid, Jarle, Jakobsdóttir, Jóhanna, Nielsen, Kaspar René, Kaspersen, Kathrine Agergård, Milani, Lili, Trogstad, Lill-Iren Schou, Yi, Lu, Bruun, Mie Topholm, Sullivan, Patrick F., Magnus, Per Minor, Shen, Qing, Nesvåg, Ragnar, Brandlistuen, Ragnhild Eek, Mägi, Reedik, Ostrowski, Sisse Rye, Løkhammer, Solveig, Solem, Stian, Reichborn-Kjennerud, Ted, Hansen, Thomas Folkmann, Werge, Thomas, Aspelund, Thor, Porteous, David J., Fang, Fang, Lehto, Kelli, Andreassen, Ole, Pedersen, Ole Birger Vesterager, Hellard, Stephanie Francoise Claire Le, Valdimarsdóttir, Unnur Anna

المصدر: dyab234 ; International Journal of Epidemiology

الوصف: publishedVersion

وصف الملف: application/pdf

العلاقة: Nordforsk: 105668; urn:issn:0300-5771; https://hdl.handle.net/11250/2976594Test; https://doi.org/10.1093/ije/dyab234Test; cristin:1980240; International Journal of Epidemiology. 2021, dyab234.

الإتاحة: https://doi.org/10.1093/ije/dyab234Test
https://hdl.handle.net/11250/2976594Test

المؤلفون: Qing Shen, Emily E. Joyce, Omid V. Ebrahimi, Maria Didriksen, Anikó Lovik, Karen Sól Sævarsdóttir, Ingibjörg Magnúsdóttir, Dorte Helenius Mikkelsen, Anna Bára Unnarsdóttir, Arna Hauksdóttir, Asle Hoffart, Anna K. Kähler, Edda Björk Thórdardóttir, Elías Eythórsson, Emma M. Frans, Gunnar Tómasson, Helga Ask, Hrönn Hardardóttir, Jóhanna Jakobsdóttir, Kelli Lehto, Li Lu, Ole A. Andreassen, Patrick F. Sullivan, Runólfur Pálsson, Christian Erikstrup, Sisse Rye Ostrowski, Thomas Werge, Thor Aspelund, Ole B. V. Pedersen, Sverre Urnes Johnson, Fang Fang, Unnur Anna Valdimarsdóttir

الوصف: BackgroundPersistence of physical symptoms after SARS-CoV-2 infection is a major public health concern, although evidence from large observational studies remain scarce. We aimed to assess the prevalence of physical symptoms in relation to acute illness severity up to more than 2-years after diagnosis of COVID-19.MethodsThis multinational study included 64 880 adult participants from Iceland, Sweden, Denmark, and Norway with self-reported data on COVID-19 and physical symptoms from April 2020 to August 2022. We compared the prevalence of 15 physical symptoms, measured by the Patient Health Questionnaire (PHQ-15), among individuals with or without a confirmed COVID-19 diagnosis, by acute illness severity, and by time since diagnosis. We additionally assessed the change in symptoms in a subset of Swedish adults with repeated measures, before and after COVID-19 diagnosis.FindingsDuring up to 27 months of follow-up, 22 382 participants (34.5%) were diagnosed with COVID-19. Individuals who were diagnosed with COVID-19, compared to those not diagnosed, had an overall 37% higher prevalence of severe physical symptom burden (PHQ-15 score ≥ 15, adjusted prevalence ratio [PR] 1.37 [95% confidence interval [CI] 1.23-1.52]). The prevalence was associated with acute COVID-19 severity: individuals bedridden for seven days or longer presented with the highest prevalence (PR 2.25[1.85-2.74]), while individuals never bedridden presented with similar prevalence as individuals not diagnosed with COVID-19 (PR 0.92 [0.68-1.24]). The prevalence was statistically significantly elevated among individuals diagnosed with COVID-19 for eight of the fifteen measured symptoms: shortness of breath, chest pain, dizziness, heart racing, headaches, low energy/fatigue, trouble sleeping, and back pain. The analysis of repeated measurements rendered similar results as the main analysis.InterpretationThese data suggest an elevated prevalence of some, but not all, physical symptoms during up to more than 2 years after diagnosis of COVID-19, particularly among individuals suffering a severe acute illness.FundingThis work was mainly supported by grants from NordForsk (COVIDMENT, grant number 105668 and 138929) and Horizon2020 (CoMorMent, 847776). See Acknowledgements for further details on funding.Research in contextEvidence before the studyAs the majority of the global population has contracted COVID-19, persistence of physical symptoms after SARS-CoV-2 infection (LongCOVID or post COVID-19 condition) has become a major public health concern. We searched PubMed for studies assessing physical symptoms after COVID-19, published by March 22, 2023. The search term was (physical symptoms after covid) AND LitCLONGCOVID [Pubmed filter]. We reviewed 82 studies, after excluding those not on humans or not published in English. High prevalence of multiple physical symptoms, mainly fatigue, shortness of breath, headache, muscle and chest pain, has been reported, mostly based on small samples of hospitalized patients confined to three to six months after diagnosis. A comprehensive assessment of long-term prevalence of physical symptoms beyond six months after diagnosis and among non-hospitalized patients is lacking.Added value of this studyWe included 64 880 participants from the general population of four Nordic countries, of whom 22 382 had been diagnosed with COVID-19 up to 2 years earlier (Implications of the available evidenceOur findings provide timely and valuable evidence to demonstrate the constitution of Long COVID and the long-term health consequences after recovery from COVID-19 in the general population. The long-term risk of severe physical symptom burden is distinctly associated with acute illness severity, highlighting the importance of sustained monitoring of physical symptoms among the group of patients who suffered severe acute illness course.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ebc58f0932f0fec68fbbcbae7ca3a8aaTest
https://doi.org/10.1101/2023.04.18.23288720Test

المؤلفون: Dehkordi, Saeid Rasekhi, Meijsen, Joeri, Mikkelsen, Dorte Helenius, Zetterberg, Richard, Shorter, John, Werge, Thomas, Buil, Alfonso

المصدر: European Neuropsychopharmacology ; volume 75, page S146 ; ISSN 0924-977X

مصطلحات موضوعية: Pharmacology (medical), Biological Psychiatry, Psychiatry and Mental health, Neurology (clinical), Neurology, Pharmacology

الإتاحة: https://doi.org/10.1016/j.euroneuro.2023.08.266Test
https://api.elsevier.com/content/article/PII:S0924977X23004200?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0924977X23004200?httpAccept=text/plainTest